GAM: Suture, Absorbable, Synthetic, Polyglycolic Acid

Product code GAM, “Suture, Absorbable, Synthetic, Polyglycolic Acid” in FDA's classification database, is a Class II device type under 21 CFR 878.4493 (absorbable poly(glycolide/l-lactide) surgical suture), reviewed by FDA's General, Plastic Surgery panel. FDA's 510(k) database lists 150 clearances under GAM, 60 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
GAM
Regulation
21 CFR 878.4493
Class
II
Panel
General, Plastic Surgery
Clearances
150
Most recent
Sep 29, 2026
Median review, last 2 years
66 days
Third-party review
Not eligible
Implant
Yes

What it covers

An absorbable poly(glycolide/l-lactide) surgical suture (PGL suture) is an absorbable sterile, flexible strand as prepared and synthesized from homopolymers of glycolide and copolymers made from 90 percent glycolide and 10 percent l-lactide, and is indicated for use in soft tissue approximation. A PGL suture meets United States Pharmacopeia (U.S.P.) requirements as described in the U.S.P. “Monograph for Absorbable Surgical Sutures;” it may be monofilament or multifilament (braided) in form; it may be uncoated or coated; and it may be undyed or dyed with an FDA-approved color additive. Also, the suture may be provided with or without a standard needle attached.

The identification in 21 CFR 878.4493, absorbable poly(glycolide/l-lactide) surgical suture. FDA gives GAM no definition of its own, so the regulation’s describes it.

FDA flags GAM devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K263073Fast Absorbing PGLARiverpoint Medical, LLCSep 29, 2026Special
K253394Coated VICRYL™ (Polyglactin 910) Plus Antibacterial SutureETHICON, Inc.Jun 25, 2026Traditional
K253530Trexon™ Monofilament Synthetic Absorbable SutureMedtronicMay 28, 2026Traditional
K253852MONOCRYL™ Plus Antibacterial Poliglecaprone – 25 (Monofilament), Sterile Synthetic Absorbable Surgical SutureETHICON, Inc.Feb 6, 2026Traditional
K252743STRATAFIX™ Spiral PDS™ Plus Knotless Tissue Control Device; STRATAFIX™ Spiral MONOCRYL™ Plus Knotless Tissue Control DeviceETHICON, Inc.Dec 22, 2025Traditional
K253620TroClose 1200Gordian Surgical, Ltd.Dec 16, 2025Special
K252820PGLA90 Poly(glycolide-co-L-lactide) Surgical Sutures (Calypso); PGLA90 Poly(glycolide-co-L-lactide) Surgical Sutures (Odysseus)Internacional Farmacéutica S.A DE C.VOct 3, 2025Special
K233265Monotime and Optime RPeters SurgicalOct 11, 2024Abbreviated
K232372Peters Surgical ADVANTIME Absorbable Suture (ADVANTIME)Peters SurgicalJul 12, 2024Abbreviated
K221527StitchKitOrigami Surgical Inc .Feb 14, 2023Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 150 with a free account)

Clearances by year

60 GAM 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)4131
2025329
20242359
20231264
20222244
2021291
20203140
2019490
2018598
20178134
20163169
20155209
201410121
20131184
2012531
2011279

Who submits

28 applicants cleared a GAM device since 2011. 67% of the clearances went to applicants in United States, then China (10%), South Korea (7%) and Israel (5%). By type: Traditional 70%, Special 23% and Abbreviated 7%.

ApplicantClearances since 2011
ETHICON, Inc.12
Foosin Medical Supplies Inc., Ltd.5
Aesculap, Inc.3
Gordian Surgical, Ltd.3
Silhouette Lift, Inc.3
Sm Eng Co., Ltd.3
Surgical Specialties Corp3
Surgical Specialties Corp. Dba Angiotech3

How FDA classifies it

Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA.” See § 878.1(e) for the availability of this guidance document.

From 21 CFR 878.4493. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 878.4493 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent GAM clearances declared.

Ask about GAM

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about GAM

What is FDA product code GAM?

Product code GAM, “Suture, Absorbable, Synthetic, Polyglycolic Acid” in FDA's classification database, is a Class II device type under 21 CFR 878.4493 (absorbable poly(glycolide/l-lactide) surgical suture), reviewed by FDA's General, Plastic Surgery panel. FDA's 510(k) database lists 150 clearances under GAM, 60 of them since 2011.

How many 510(k) clearances are there under GAM?

FDA’s 510(k) database listed 150 clearances under GAM as of Oct 29, 2026, 60 of them decided since 2011; the most recent decision was Sep 29, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a GAM 510(k)?

For the 7 GAM clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 66 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most GAM clearances?

Since 2011: ETHICON, Inc. (12), Foosin Medical Supplies Inc., Ltd. (5), Aesculap, Inc. (3), Gordian Surgical, Ltd. (3) and Silhouette Lift, Inc. (3). 28 applicants have cleared a GAM device in that time.

Sources

  1. FDA product classification: GAM · Product Classification database
  2. 21 CFR 878.4493: Absorbable poly(glycolide/l-lactide) surgical suture · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for GAM · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow GAMGet an email when FDA clears, recalls or publishes guidance for GAM devices.

Know what FDA already cleared.